You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
羅欣藥業(002793.SZ):擬向北京健康增資5000萬元
格隆匯 04-20 16:48

格隆匯4月20日丨羅欣藥業(002793.SZ)公佈,公司之控股子公司北京健康目前註冊資本為人民幣5,000萬元,擬增加註冊資本人民幣5000萬元,公司擬以自有資金人民幣5000萬元的價格認購北京健康上述增加的註冊資本。本次增資完成後,北京健康的註冊資本變更為人民幣1億元。就本次增資,北京健康的其他現有股東成都得怡欣華股權投資合夥企業(有限合夥)(下稱“得怡成都”)作為公司關聯方書面同意放棄向北京健康按照其實繳的出資比例優先認繳出資的權利。

本次增資完成後,公司對北京健康持股比例將由66.66%升至83.33%,仍為其控股股東並繼續將其納入合併報表範圍。得怡成都作為公司控股股東之一致行動人,屬於公司關聯方,其持有北京健康的股權比例將由33.34%降至16.67%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account